Funding cuts from the National Institutes of Health (NIH) have impacted more than 74,000 enrolled participants in various medical studies.Disruptions caused by funding halts affected studies for conditions like cancer, heart disease, and infectious diseases such as COVID-19, leading to delays and cancellations of trial participation.